Red Cell Distribution With to Lymphocyte Ratio in Cardiac Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-15

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is aimed to investigate whether red cell distribution with (RDW) to lymphocyte ratio (RLR) can predict early comorbidity among cardiac surgery patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Preoperative Values on Mortality in Patients Undergoing Open Heart Surgery

NCT04741555

Mechanical Ventilation Coronary Bypass Surgery Postoperative Complications

COMPLETED

Relation Between Insulinoresistance and Neutrophile to Lymphocyte Ratio in Cardiac Surgery.

NCT06945536

Insulin Resistance Cardiac Surgery Requiring Cardiopulmonary Bypass Neutrophil Lymphocyte Ratio

COMPLETED

Red Cell Distribution Width as a Predictor for Post Operative Atrial Fibrillation After Open Heart Surgries

NCT06286111

Atrial Fibrillation Inflammatory Marker Heart; Surgery, Heart, Functional Disturbance as Result

ACTIVE_NOT_RECRUITING

Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery

NCT01353157

Heart; Dysfunction Postoperative, Cardiac Surgery Cytokine Release Syndrome

COMPLETED

NLR and Emergency Surgery

NCT06549101

Emergency Surgery

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are important developments in the field of cardiac surgery due to advances in medical treatments, surgical techniques, intraoperative anesthesia management, and postoperative intensive care. On the other hand, the proportion of high-risk patients has increased due to the increasing number of elderly patients with comorbidities presenting for cardiac surgery. It is important to analyze outcomes such as postoperative morbidity and mortality, due to concerns about the quality of life of patients after cardiac operations, the recommendations of current ERAS protocols, and the shortening of intensive care unit length of stay. Complications such as cardiac, pulmonary, renal, and neurological disorders, infections such as pneumonia or sepsis, and prolonged stay in the intensive care unit and hospital are indicators of not only the quality of care but also the quality of life after cardiac surgery. Therefore, it is important to determine the perioperative risk factors that cause postoperative morbidity. Various outcome prediction models are used for cardiac surgery, such as the Cardiac Anesthesia Risk Assessment score, Tuman score, Tu score, and the European System for Cardiac Operative Risk Assessment score, which uses preoperative factors to predict the postoperative outcomes. It is known that intraoperative factors such as CPB duration, aortic cross-clamp time, surgical technique, and serum lactate levels are associated with postoperative morbidity. Recent studies suggest that inflammatory and immune imbalance may play an important role in postoperative complications. Studies point to new parameters derived from preoperative complete blood count as potential biomarkers of inflammation and oxidative stress. Many markers such as Neutrophil/Lymphocyte ratio, Mean platelet volume (MPV) or RDW alone have been studied in cardiac surgery. The ratio of red cell distribution width (RDW) to lymphocyte (L) has been popular in recent years as an indicator of poor prognosis, especially in oncological patients. However, this marker has not yet been evaluated in terms of morbidity or mortality in cardiac surgery patients.

The main purpose of this study; To investigate the RDW/L ratio as an early morbidity marker in cardiac surgery patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Postoperative complications +

Patients who have postoperative complications during hospital stay after cardiac surgery

No interventions assigned to this group

Postoperative complications -

Patients who have not postoperative complications during hospital stay after cardiac surgery

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients undergoing open-heart surgery with cardiopulmonary bypass

Exclusion Criteria

* Re-operations
* Emergency operations
* Patients with preoperative renal failure
* Patients with preoperative hematological problems
* Patients with preoperative infection
* Patients with preoperative immunological disease
* Patients using preoperative steroids

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No